The FDA has raised concerns about compounded GLP-1 products and has received reports of adverse events linked to compounded tirzepatide
Atherosclerosis develops when cholesterol-rich plaque accumulates within artery walls
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy
These included gastrointestinal lesions, pancreatic injury, hepatic damage, cardiac tissue impairment, endothelial disruption, and alterations in vascular pressure regulation
These include: Nausea (very common, affecting more than 1 in 10 patients) Diarrhoea and vomiting (common) Constipation and abdominal pain (common) Dyspepsia and flatulence (common) These symptoms typically diminish over time as the body adjusts to the medication
Some patients breeze through this phase with minimal discomfort, while others find it more challenging